Coherus BioSciences, Inc. (NASDAQ:CHRS) On The Verge Of Breaking Even

Simply Wall StNov 27 05:33 ET

Truist Financial Initiates Coherus BioSciences(CHRS.US) With Buy Rating

Moomoo NewsNov 19 07:33 ET · Ratings

Barclays Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 18 04:33 ET · Ratings

Coherus Biosciences (CHRS) Receives a Buy From Barclays

TipRanksNov 18 04:07 ET · Ratings

Coherus BioSciences Is Maintained at Outperform by Baird

Dow JonesNov 8 07:38 ET · Ratings

Baird Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsNov 8 07:35 ET · Ratings